HMP Global Acquires Drug Channels Institute
January 4, 2024
HMP Global has entered into a definitive agreement to acquire Drug Channels Institute (DCI), a provider of pharmaceutical market intelligence and analysis. The acquisition will fold DCI into HMP Market Access Insights to create a new market intelligence division, expanding HMP Global's research capabilities and services for clients across the pharmaceutical ecosystem.
- Buyers
- HMP Global
- Targets
- Drug Channels Institute
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.